ICMR backed Covaxin could be ready by June 2021 ; Bharat Biotech

▴ ICMR backed Covaxin could be ready by June 2021 ; Bharat Biotech
In the latest update on coronavirus vaccine, Covaxin, which is backed by the Indian Council for Medical Research and being developed by Bharat Biotech, is expected to be ready by June 2021.

Officials of Bharat Biotech have revealed that its coronavirus vaccine candidate Covaxin is expected to be ready by June 2021. Earlier on Thursday, the Drug Controller General of India (DGCI) allowed Bharat Biotech International Limited to conduct the Phase III trials of its Covid-19 vaccine candidate Covaxin.

Covaxin expected to be ready by June 2021
According to a report in the Indian Express, a top company official informed that Covaxin should be ready by June 2021-- unless the government advances its launch through emergency use authorisation.

"If we get all the approvals in place, I think during Q2 of 2021, we should get the efficacy readout from our phase-3 clinical trial — April, May, June, for example. That is for the full efficacy results," Sai Prasad, executive director, Bharat Biotech International Ltd, told The Indian Express.

Developed by Bharat Biotech along with the Indian Council of Medical Research and National Institute of Virology, Covaxin is India's first indigenous vaccine candidate against the Covid-19.

'Government may consider emergency use approval'
The official further said, "We are committed to doing all our phase-1, phase-2 and phase-3 clinical trials in its entirety, but I think the government may also be considering emergency use approval".

According to Indian Express, Prasad said that however, the firm is not pushing for such an approval.

“Our intent is to develop everything to its logical conclusion in terms of empirical evidence and data, and efficacy data and safety data. But there are discussions, I guess, within the government about that (emergency use approval),” he told Indian Express.

Story Source ; www.indiatoday.in 

Tags : #Covaxin #BharatBiotech #DCGI #LatestVaccineNewsOct24 #ICMR

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

Alembic Pharmaceuticals announces USFDA Final Approval for Metolazone TabletsDecember 03, 2020
QuEST Global provides COVID-19 support kits to more than 1,000 Police Officers in the cityDecember 03, 2020
Gujarat: Series of events mark ‘International Day of Persons with Disabilities’December 03, 2020
Number of COVID-19 positive cases rise in Mizoram, while COVID-19 recovery rate in Tripura improves December 03, 2020
IPC Statement On SARS-CoV-2 Vaccines And PsoriasisDecember 03, 2020
Roche receives USFDA emergency use authorization for new test to measure the level of SARS-CoV-2 antibodiesDecember 03, 2020
Country's COVID recovery rate reaches 94.11 per centDecember 03, 2020
Moderna CEO expects emergency use nod for COVID-19 vaccine after FDA panel meetDecember 03, 2020
Britain becomes first country in world to approve coronavirus vaccineDecember 03, 2020
Roche announces FDA approval of Gavreto for people with advanced or metastatic RET-mutant and RET fusion-positive thyroid cancersDecember 03, 2020
Alembic Pharmaceuticals announces USFDA Final Approval for Metolazone Tablets USPDecember 03, 2020
Replacing red meat with plant foods may reduce the risk of heart diseaseDecember 03, 2020
Birth defects linked to greater risk of cancer in later lifeDecember 03, 2020
Combining telemedicine with AI will increase the productivity of clinicians and quality of care says Srinivas Prasad M R, Member, CII National Committee on Technology and R&DDecember 03, 2020
COVID is an opportunity to reshape the healthcare industry in India says Saurabh Bajpayee, Founder, Oxygenta HealthcareDecember 03, 2020
Second Covid wave expected to hit Karnataka in Jan-FebDecember 03, 2020
COVID19 cases: Maharashtra sees around 50% drop in November compared to October and SeptemberDecember 03, 2020
Moleculin announces FDA approval of 3 Rare pediatric disease designations for WP1066December 03, 2020
Health Decisions and OncoBay Clinical partners for development services in women's oncologyDecember 03, 2020
Impose Community service as penalty on those found violating COVID-19 safety norms: Gujarat High CourtDecember 03, 2020